News

Article

NeurologyLive® Friday 5 — December 13, 2024

Key Takeaways

  • Recognition and advocacy are crucial in multiple sclerosis care, with nurses playing a pivotal role in patient support and mentorship.
  • Stem cell therapies hold potential for restoring neural function in epilepsy, offering hope for regenerative treatment approaches.
SHOW MORE

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 13, 2024.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Honoring the Impact of Recognition and Advocacy in MS Care: Aprile Royal, RN, BA, MEd

The manager of the BARLO MS education program at St. Michael's Hospital highlighted the significance of recognition, the pivotal role of nurses in multiple sclerosis care, and the lasting impact of mentorship and advocacy. [WATCH TIME: 5 minutes]

Honoring the Impact of Recognition and Advocacy in MS Care: Aprile Royal, RN, BA, MEd

2: Promise Behind Stem Cell Approaches to Treat Epilepsy: Jonathan Parker, MD, PhD

The assistant professor of neurosurgery and neuroscience at Mayo Clinic Arizona provided context on the potential of regenerative therapies like stem cells to restore neural function in patients with epilepsy. [WATCH TIME: 3 minutes]

Promise Behind Stem Cell Approaches to Treat Epilepsy: Jonathan Parker, MD, PhD

3: A Subspecialty for Half the World’s Population: Women’s Neurology

A new feature, in collaboration with NeurologyLive® and the International Journal of MS Care, brings perspectives from both the research and clinical community on women’s brain health as a subspecialty in neurology.

A Subspecialty for Half the World’s Population: Women’s Neurology

4: NeuroVoices: Alexander C. Whiting, MD, on Advancing Epilepsy Surgery and Brain Function Research

In our latest Q&A for NeuroVoices, the director of epilepsy surgery at Allegheny Health Network discussed how clinicians can successfully pinpoint the source of epilepsy in the brain through innovative procedures like stereo electroencephalography.

NeuroVoices: Alexander C. Whiting, MD, on Advancing Epilepsy Surgery and Brain Function Research

5: NMOSD Management with New FDA-approved Agents to Reduce Relapse and Hospitalization Rates

A panelist discusses how neurologists can adapt their NMOSD management strategies based on recent findings about relapse and hospitalization rates, sharing practical advice and clinical experience for optimizing patient outcomes.

NMOSD Management with New FDA-approved Agents to Reduce Relapse and Hospitalization Rates

Related Videos
Alexander C. Whiting, MD
Aprile Royal, RN, BA, MEd
2 experts in this video
Michael Levy, MD, PhD, is featured in this series.
2 experts in this video
© 2024 MJH Life Sciences

All rights reserved.